Lexaria Bioscience Corp (LEXX)

Jun 16, 2025

LEXX: GLP-1-H25-5 Study Complete - Yahoo Finance

Jun 16, 2025

Jun 12, 2025

Lexaria Bioscience announces completion of GLP-1-H25-5 study - Yahoo Finance

Jun 12, 2025

Jun 11, 2025

Lexaria’s Oral Liraglutide Shows Promise in Reducing Adverse Events - TipRanks

Jun 11, 2025

Jun 11, 2025

Lexaria Bioscience (LEXX) Reports Promising Results for Oral Liraglutide Study | LEXX Stock News - GuruFocus

Jun 11, 2025

Jun 11, 2025

Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule | LEXX Stock News - GuruFocus

Jun 11, 2025

Jun 11, 2025

Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule - TradingView

Jun 11, 2025

Jun 11, 2025

GLP-1 Breakthrough: Oral Liraglutide Shows 67% Less Nausea in Clinical Trial | LEXX Stock News - Stock Titan

Jun 11, 2025

Jun 06, 2025

Lexaria Bioscience (NASDAQ:LEXX) Trading Up 4.3% – Still a Buy? - Defense World

Jun 06, 2025

Jun 05, 2025

Lexaria Bioscience to Engage with Industry Leaders at BIO International Convention - TipRanks

Jun 05, 2025

Jun 05, 2025

Lexaria Attending BIO International Convention | LEXX Stock News - GuruFocus

Jun 05, 2025

Jun 05, 2025

Lexaria Attending BIO International Convention - TradingView

Jun 05, 2025

Jun 05, 2025

Lexaria Targets Weight Loss and Diabetes Partnerships at Massive BIO Convention with 20,000 Attendees - Stock Titan

Jun 05, 2025

Jun 04, 2025

Lexaria Bioscience stock hits 52-week low at $0.94 By Investing.com - Investing.com South Africa

Jun 04, 2025

Jun 03, 2025

Lexaria Bioscience stock hits 52-week low at $0.94 - Investing.com

Jun 03, 2025

May 27, 2025

Lexaria Bioscience Corp (NASDAQ: LEXX) Is Down -15.79% Since Its Low, And It’s Only Getting Started. - Stocksregister

May 27, 2025

May 14, 2025

Lexaria advances drug delivery tech with PharmaCO By Investing.com - Investing.com Nigeria

May 14, 2025

May 14, 2025

Raymond James Financial Inc. Makes New Investment in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World

May 14, 2025

May 12, 2025

Lexaria (LEXX) Advances Collaborative Pharmaceutical Research | - GuruFocus

May 12, 2025

May 12, 2025

Lexaria Advances Collaboration with Pharma Partner on Drug Delivery Technology - TipRanks

May 12, 2025

May 12, 2025

Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company - marketscreener.com

May 12, 2025

May 12, 2025

Lexaria Provides Update on Material Transfer Agreement with Phar - GuruFocus

May 12, 2025

May 03, 2025

Geode Capital Management LLC Increases Position in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World

May 03, 2025

May 01, 2025

Lexaria Bioscience announces $2M registered direct offering; shares slip 19% - MSN

May 01, 2025

Apr 30, 2025

Lexaria Bioscience stock hits 52-week low at $1.14 By Investing.com - Investing.com India

Apr 30, 2025

Apr 30, 2025

Lexaria Bioscience stock hits 52-week low at $1.14 - Investing.com Australia

Apr 30, 2025

Apr 28, 2025

Lexaria Announces Closing of $2 Million Registered Direct Offeri - GuruFocus

Apr 28, 2025

Apr 28, 2025

Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock - Yahoo Finance

Apr 28, 2025

Apr 28, 2025

Lexaria Bioscience Secures $2 Million in Direct Stock Offering - TipRanks

Apr 28, 2025

Apr 28, 2025

Lexaria Secures $2M Strategic Investment in Clean Direct Offering Amid Market Turbulence - Stock Titan

Apr 28, 2025

Apr 28, 2025

Market Watch Highlights: Lexaria Bioscience Corp (LEXX) Ends on an Downturn Note at 1.35 - DWinneX

Apr 28, 2025

Apr 28, 2025

Lexaria Bioscience Corp (LEXX) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

Apr 28, 2025

Apr 28, 2025

What is Zacks Small Cap’s Estimate for LEXX FY2025 Earnings? - Defense World

Apr 28, 2025

Apr 25, 2025

Lexaria Bioscience (LEXX) Announces $2M Direct Offering | LEXX S - GuruFocus

Apr 25, 2025

Apr 25, 2025

Lexaria Bioscience Secures $2 Million in Registered Direct Stock Offering - citybuzz -

Apr 25, 2025

Apr 25, 2025

Lexaria Announces $2 Million Registered Direct Offering of Commo - GuruFocus

Apr 25, 2025

Apr 25, 2025

Lexaria Bioscience secures $2 million in direct offering By Investing.com - Investing.com South Africa

Apr 25, 2025

Apr 25, 2025

Lexaria Bioscience secures $2 million in direct offering - Investing.com

Apr 25, 2025

Apr 25, 2025

Lexaria Announces $2 Million Registered Direct Offering of Common Stock - TradingView

Apr 25, 2025

Apr 25, 2025

Lexaria Lands $2M Strategic Investment: Institutional Investor Backs Biotech at $1.00 Per Share - Stock Titan

Apr 25, 2025

Apr 25, 2025

Lexaria Bioscience (OTCMKTS:LXRP) versus U.S. Gold (NASDAQ:USAU) Critical Comparison - Defense World

Apr 25, 2025

Apr 24, 2025

LEXXLexaria Bioscience Corp Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 24, 2025

LEXX: Second Quarter Results - Yahoo Finance

Apr 24, 2025

Apr 23, 2025

Lexaria Bioscience (LEXX) Advances in GLP-1 Technology Amid Indu - GuruFocus

Apr 23, 2025